Shiv Kumar Agarwal
Concepts (241)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 1 | 9 | 2023 | 200 | 4.870 |
Why?
| Percutaneous Coronary Intervention | 14 | 2022 | 336 | 3.320 |
Why?
| Fractional Flow Reserve, Myocardial | 9 | 2022 | 142 | 2.590 |
Why?
| Coronary Artery Disease | 9 | 2022 | 326 | 2.220 |
Why?
| Coronary Stenosis | 3 | 2021 | 107 | 1.420 |
Why?
| Coronary Occlusion | 3 | 2021 | 80 | 1.040 |
Why?
| Coronary Angiography | 11 | 2022 | 411 | 1.020 |
Why?
| Diabetes Mellitus | 2 | 2023 | 307 | 0.870 |
Why?
| Treatment Outcome | 20 | 2022 | 5596 | 0.860 |
Why?
| Technology | 4 | 2022 | 18 | 0.860 |
Why?
| Racism | 1 | 2023 | 51 | 0.850 |
Why?
| Iodide Peroxidase | 1 | 2021 | 4 | 0.840 |
Why?
| Podocytes | 1 | 2021 | 24 | 0.820 |
Why?
| Homeostasis | 1 | 2021 | 223 | 0.750 |
Why?
| Humans | 50 | 2023 | 54132 | 0.750 |
Why?
| Aneurysm, False | 1 | 2020 | 48 | 0.730 |
Why?
| Hemodynamics | 2 | 2017 | 291 | 0.670 |
Why?
| Myocardial Ischemia | 2 | 2016 | 129 | 0.630 |
Why?
| Coronary Vessels | 5 | 2021 | 197 | 0.620 |
Why?
| Renal Dialysis | 6 | 2018 | 191 | 0.580 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2022 | 484 | 0.560 |
Why?
| Angioplasty, Balloon | 2 | 2019 | 74 | 0.550 |
Why?
| Cardiac Catheterization | 4 | 2020 | 257 | 0.540 |
Why?
| Pericardiectomy | 1 | 2015 | 4 | 0.530 |
Why?
| Postpericardiotomy Syndrome | 1 | 2015 | 4 | 0.530 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2015 | 577 | 0.520 |
Why?
| Blood Glucose | 3 | 2022 | 491 | 0.520 |
Why?
| Arteriovenous Shunt, Surgical | 1 | 2015 | 37 | 0.520 |
Why?
| Pericarditis | 1 | 2015 | 21 | 0.520 |
Why?
| Colchicine | 1 | 2015 | 35 | 0.510 |
Why?
| Secondary Prevention | 1 | 2015 | 89 | 0.510 |
Why?
| Acute Kidney Injury | 5 | 2018 | 404 | 0.510 |
Why?
| Hypertension | 3 | 2020 | 562 | 0.490 |
Why?
| Awareness | 1 | 2014 | 33 | 0.490 |
Why?
| Young Adult | 11 | 2023 | 4320 | 0.480 |
Why?
| Emigrants and Immigrants | 1 | 2014 | 38 | 0.470 |
Why?
| Stents | 5 | 2022 | 375 | 0.460 |
Why?
| Male | 31 | 2023 | 27350 | 0.450 |
Why?
| Middle Aged | 21 | 2022 | 13094 | 0.430 |
Why?
| Blood Glucose Self-Monitoring | 2 | 2022 | 38 | 0.430 |
Why?
| Hospitalization | 5 | 2022 | 704 | 0.380 |
Why?
| Aged | 19 | 2020 | 10059 | 0.380 |
Why?
| Prostatic Neoplasms | 2 | 2023 | 411 | 0.350 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 540 | 0.350 |
Why?
| Retrospective Studies | 12 | 2022 | 6387 | 0.330 |
Why?
| United States | 10 | 2022 | 5172 | 0.330 |
Why?
| Time Factors | 8 | 2020 | 3223 | 0.320 |
Why?
| Predictive Value of Tests | 7 | 2022 | 1053 | 0.320 |
Why?
| Drug-Eluting Stents | 3 | 2018 | 115 | 0.310 |
Why?
| Female | 21 | 2021 | 28437 | 0.310 |
Why?
| Risk Factors | 11 | 2022 | 3936 | 0.310 |
Why?
| Angioplasty, Balloon, Coronary | 2 | 2018 | 167 | 0.270 |
Why?
| Hospital Mortality | 5 | 2022 | 464 | 0.250 |
Why?
| Adult | 12 | 2022 | 14196 | 0.250 |
Why?
| Receptors, CXCR | 1 | 2023 | 1 | 0.240 |
Why?
| Kinetochores | 1 | 2023 | 3 | 0.240 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2023 | 44 | 0.230 |
Why?
| Receptors, Androgen | 1 | 2023 | 51 | 0.230 |
Why?
| Microtubule-Associated Proteins | 1 | 2023 | 78 | 0.230 |
Why?
| Odds Ratio | 4 | 2017 | 603 | 0.220 |
Why?
| Hyperglycemia | 1 | 2022 | 86 | 0.210 |
Why?
| Heart Failure | 2 | 2018 | 538 | 0.210 |
Why?
| Puromycin Aminonucleoside | 1 | 2021 | 2 | 0.210 |
Why?
| Integrin alphaVbeta3 | 1 | 2021 | 3 | 0.210 |
Why?
| Receptors, Thyrotropin | 1 | 2021 | 7 | 0.210 |
Why?
| Hypotension, Controlled | 1 | 2021 | 3 | 0.210 |
Why?
| Triiodothyronine | 1 | 2021 | 30 | 0.210 |
Why?
| Cell Cycle Proteins | 1 | 2023 | 198 | 0.210 |
Why?
| Thyroid Hormones | 1 | 2021 | 18 | 0.210 |
Why?
| Proteinuria | 1 | 2021 | 52 | 0.200 |
Why?
| Nuclear Proteins | 1 | 2023 | 252 | 0.200 |
Why?
| Minority Groups | 1 | 2022 | 135 | 0.200 |
Why?
| Multivariate Analysis | 3 | 2017 | 646 | 0.190 |
Why?
| Kaplan-Meier Estimate | 3 | 2017 | 514 | 0.190 |
Why?
| Aortic Valve Stenosis | 1 | 2022 | 77 | 0.190 |
Why?
| Heart Valve Prosthesis | 1 | 2022 | 91 | 0.190 |
Why?
| Pericardium | 1 | 2020 | 29 | 0.190 |
Why?
| Aorta | 2 | 2019 | 182 | 0.190 |
Why?
| Quality Improvement | 1 | 2022 | 242 | 0.190 |
Why?
| Diabetes Complications | 1 | 2020 | 124 | 0.180 |
Why?
| Heart-Assist Devices | 2 | 2018 | 148 | 0.180 |
Why?
| Prevalence | 1 | 2023 | 1023 | 0.180 |
Why?
| Reproducibility of Results | 2 | 2021 | 1307 | 0.180 |
Why?
| Enbucrilate | 1 | 2019 | 6 | 0.180 |
Why?
| Tissue Adhesives | 1 | 2019 | 15 | 0.180 |
Why?
| Area Under Curve | 2 | 2016 | 205 | 0.180 |
Why?
| Arterial Pressure | 1 | 2019 | 50 | 0.180 |
Why?
| Heart Injuries | 1 | 2019 | 20 | 0.180 |
Why?
| Brain Ischemia | 2 | 2015 | 164 | 0.170 |
Why?
| Follow-Up Studies | 4 | 2018 | 2384 | 0.170 |
Why?
| Prognosis | 4 | 2018 | 2116 | 0.170 |
Why?
| Mice, Knockout | 1 | 2021 | 941 | 0.170 |
Why?
| Exercise Test | 2 | 2016 | 148 | 0.160 |
Why?
| Healthcare Disparities | 1 | 2021 | 267 | 0.160 |
Why?
| Signal Transduction | 2 | 2023 | 1754 | 0.160 |
Why?
| Cells, Cultured | 1 | 2021 | 1755 | 0.150 |
Why?
| Population Surveillance | 1 | 2018 | 183 | 0.150 |
Why?
| Atrial Fibrillation | 2 | 2016 | 197 | 0.150 |
Why?
| Transition to Adult Care | 1 | 2016 | 13 | 0.150 |
Why?
| Algorithms | 1 | 2021 | 697 | 0.150 |
Why?
| Hyperemia | 1 | 2016 | 23 | 0.150 |
Why?
| Lower Extremity | 1 | 2017 | 103 | 0.150 |
Why?
| Angina, Stable | 1 | 2016 | 8 | 0.150 |
Why?
| Angina, Unstable | 1 | 2016 | 27 | 0.150 |
Why?
| Patient Discharge | 2 | 2018 | 352 | 0.140 |
Why?
| Recurrence | 2 | 2016 | 692 | 0.140 |
Why?
| Incidence | 5 | 2018 | 1084 | 0.140 |
Why?
| Adenosine | 1 | 2016 | 71 | 0.140 |
Why?
| Peripheral Arterial Disease | 1 | 2017 | 88 | 0.140 |
Why?
| Vasodilator Agents | 1 | 2016 | 111 | 0.140 |
Why?
| Ventricular Function, Left | 2 | 2018 | 181 | 0.140 |
Why?
| Mice, Inbred C57BL | 1 | 2021 | 2021 | 0.140 |
Why?
| Chest Pain | 1 | 2016 | 65 | 0.140 |
Why?
| Patient Readmission | 1 | 2018 | 242 | 0.140 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2015 | 29 | 0.130 |
Why?
| Streptococcus pyogenes | 1 | 2015 | 17 | 0.130 |
Why?
| Vascular Surgical Procedures | 1 | 2017 | 179 | 0.130 |
Why?
| Kidney Failure, Chronic | 1 | 2017 | 229 | 0.130 |
Why?
| Stroke | 2 | 2015 | 522 | 0.130 |
Why?
| Constriction, Pathologic | 1 | 2015 | 104 | 0.130 |
Why?
| Acute Coronary Syndrome | 1 | 2016 | 91 | 0.130 |
Why?
| Vascular Patency | 1 | 2015 | 93 | 0.130 |
Why?
| Tubulin Modulators | 1 | 2015 | 40 | 0.130 |
Why?
| Serositis | 1 | 2014 | 1 | 0.130 |
Why?
| Cerebral Hemorrhage | 1 | 2015 | 102 | 0.130 |
Why?
| Endovascular Procedures | 1 | 2017 | 186 | 0.130 |
Why?
| Virulence Factors | 1 | 2015 | 92 | 0.120 |
Why?
| Anti-Inflammatory Agents | 1 | 2015 | 177 | 0.120 |
Why?
| Databases, Factual | 4 | 2017 | 685 | 0.120 |
Why?
| Lithium | 1 | 2013 | 40 | 0.120 |
Why?
| Arkansas | 2 | 2016 | 2103 | 0.110 |
Why?
| Bradycardia | 1 | 2013 | 34 | 0.110 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2015 | 244 | 0.110 |
Why?
| Severity of Illness Index | 2 | 2015 | 1084 | 0.110 |
Why?
| Echocardiography, Stress | 1 | 2012 | 8 | 0.110 |
Why?
| Calcium | 1 | 2015 | 434 | 0.110 |
Why?
| Mice | 2 | 2021 | 6436 | 0.110 |
Why?
| Clostridium septicum | 1 | 2012 | 2 | 0.110 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2014 | 239 | 0.110 |
Why?
| Aortitis | 1 | 2012 | 5 | 0.110 |
Why?
| Dyspnea | 1 | 2012 | 78 | 0.110 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 436 | 0.110 |
Why?
| Patient Satisfaction | 1 | 2014 | 304 | 0.100 |
Why?
| Plaque, Atherosclerotic | 1 | 2012 | 47 | 0.100 |
Why?
| Stroke Volume | 1 | 2012 | 151 | 0.100 |
Why?
| Arthroplasty, Replacement, Hip | 1 | 2016 | 251 | 0.100 |
Why?
| Adolescent | 6 | 2020 | 6890 | 0.100 |
Why?
| Arthroplasty, Replacement, Knee | 1 | 2016 | 282 | 0.100 |
Why?
| Clostridium Infections | 1 | 2012 | 62 | 0.100 |
Why?
| Postoperative Complications | 1 | 2018 | 1036 | 0.100 |
Why?
| HIV Infections | 1 | 2015 | 394 | 0.100 |
Why?
| Clinical Competence | 1 | 2014 | 447 | 0.090 |
Why?
| Logistic Models | 3 | 2017 | 991 | 0.090 |
Why?
| Tomography, X-Ray Computed | 1 | 2015 | 1210 | 0.090 |
Why?
| Cell Proliferation | 2 | 2023 | 1099 | 0.080 |
Why?
| Cell Line, Tumor | 2 | 2023 | 1542 | 0.080 |
Why?
| Child | 1 | 2021 | 7312 | 0.080 |
Why?
| Animals | 3 | 2021 | 14435 | 0.080 |
Why?
| Registries | 2 | 2021 | 548 | 0.080 |
Why?
| Chi-Square Distribution | 2 | 2017 | 318 | 0.070 |
Why?
| Prospective Studies | 3 | 2020 | 2607 | 0.070 |
Why?
| Length of Stay | 2 | 2018 | 683 | 0.060 |
Why?
| Comorbidity | 2 | 2016 | 666 | 0.060 |
Why?
| Chromosome Segregation | 1 | 2023 | 13 | 0.060 |
Why?
| Acyltransferases | 1 | 2023 | 27 | 0.060 |
Why?
| Survival Analysis | 2 | 2015 | 739 | 0.060 |
Why?
| Microtubules | 1 | 2023 | 57 | 0.060 |
Why?
| Sepsis | 2 | 2016 | 253 | 0.060 |
Why?
| Androgens | 1 | 2023 | 71 | 0.060 |
Why?
| Mitosis | 1 | 2023 | 107 | 0.060 |
Why?
| Reperfusion Injury | 1 | 2004 | 119 | 0.050 |
Why?
| Hospitals | 1 | 2022 | 179 | 0.050 |
Why?
| Parity | 1 | 2020 | 51 | 0.050 |
Why?
| Aortic Valve | 1 | 2022 | 113 | 0.050 |
Why?
| Ischemia | 1 | 2021 | 175 | 0.050 |
Why?
| Cross-Sectional Studies | 2 | 2016 | 1678 | 0.050 |
Why?
| Materials Testing | 1 | 2019 | 62 | 0.040 |
Why?
| Sex Factors | 1 | 2022 | 770 | 0.040 |
Why?
| Catheterization | 1 | 2019 | 109 | 0.040 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2023 | 867 | 0.040 |
Why?
| Feasibility Studies | 1 | 2020 | 398 | 0.040 |
Why?
| Limb Salvage | 1 | 2017 | 40 | 0.040 |
Why?
| Disease Models, Animal | 1 | 2004 | 1645 | 0.040 |
Why?
| Ventricular Dysfunction, Left | 1 | 2018 | 99 | 0.040 |
Why?
| Cohort Studies | 1 | 2022 | 1549 | 0.040 |
Why?
| Prosthesis Design | 1 | 2018 | 260 | 0.040 |
Why?
| Population Growth | 1 | 2016 | 2 | 0.040 |
Why?
| Liver Failure | 1 | 2016 | 27 | 0.040 |
Why?
| Hospital Costs | 1 | 2017 | 84 | 0.040 |
Why?
| Chronic Disease | 1 | 2019 | 611 | 0.040 |
Why?
| Propensity Score | 1 | 2017 | 137 | 0.040 |
Why?
| Counseling | 1 | 2016 | 147 | 0.030 |
Why?
| ROC Curve | 1 | 2016 | 260 | 0.030 |
Why?
| Proportional Hazards Models | 1 | 2017 | 428 | 0.030 |
Why?
| Self Care | 1 | 2016 | 143 | 0.030 |
Why?
| Long-Term Care | 1 | 2015 | 57 | 0.030 |
Why?
| Survival Rate | 1 | 2018 | 955 | 0.030 |
Why?
| Respiratory Insufficiency | 1 | 2016 | 129 | 0.030 |
Why?
| Incidental Findings | 1 | 2015 | 42 | 0.030 |
Why?
| Arthritis, Psoriatic | 1 | 2014 | 11 | 0.030 |
Why?
| Radiography, Thoracic | 1 | 2015 | 70 | 0.030 |
Why?
| Streptococcal Infections | 1 | 2015 | 58 | 0.030 |
Why?
| Risk Assessment | 1 | 2019 | 1363 | 0.030 |
Why?
| Virulence | 1 | 2015 | 194 | 0.030 |
Why?
| Cell Division | 1 | 2015 | 330 | 0.030 |
Why?
| Gene Regulatory Networks | 1 | 2015 | 125 | 0.030 |
Why?
| New York City | 1 | 2014 | 24 | 0.030 |
Why?
| Sequence Analysis, DNA | 1 | 2015 | 277 | 0.030 |
Why?
| Internal Medicine | 1 | 2014 | 24 | 0.030 |
Why?
| Respiration, Artificial | 1 | 2016 | 285 | 0.030 |
Why?
| Gene Deletion | 1 | 2015 | 296 | 0.030 |
Why?
| Hospitals, Teaching | 1 | 2014 | 58 | 0.030 |
Why?
| Epithelial Cells | 1 | 2015 | 256 | 0.030 |
Why?
| Molecular Sequence Data | 1 | 2015 | 996 | 0.030 |
Why?
| Pregnancy | 1 | 2020 | 2614 | 0.030 |
Why?
| Myocardial Infarction | 1 | 2017 | 423 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2015 | 743 | 0.030 |
Why?
| Renal Insufficiency, Chronic | 1 | 2015 | 183 | 0.030 |
Why?
| Cell Line | 1 | 2015 | 1166 | 0.030 |
Why?
| Microbial Sensitivity Tests | 1 | 2012 | 289 | 0.020 |
Why?
| Gene Expression Profiling | 1 | 2015 | 1138 | 0.020 |
Why?
| Internship and Residency | 1 | 2014 | 498 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 2012 | 816 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2012 | 3442 | 0.020 |
Why?
| Papio | 1 | 2004 | 15 | 0.020 |
Why?
| E-Selectin | 1 | 2004 | 19 | 0.020 |
Why?
| Blood Gas Analysis | 1 | 2004 | 31 | 0.020 |
Why?
| P-Selectin | 1 | 2004 | 33 | 0.020 |
Why?
| Blood Cell Count | 1 | 2004 | 43 | 0.020 |
Why?
| Water-Electrolyte Balance | 1 | 2004 | 40 | 0.020 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2004 | 55 | 0.020 |
Why?
| Orbit | 1 | 2004 | 35 | 0.010 |
Why?
| Carotid Arteries | 1 | 2004 | 84 | 0.010 |
Why?
| Neurologic Examination | 1 | 2004 | 76 | 0.010 |
Why?
| Cerebral Arteries | 1 | 2004 | 36 | 0.010 |
Why?
| Postoperative Care | 1 | 2004 | 122 | 0.010 |
Why?
| Anesthesia | 1 | 2004 | 79 | 0.010 |
Why?
| Blood Pressure | 1 | 2004 | 586 | 0.010 |
Why?
| Antibodies, Monoclonal | 1 | 2004 | 560 | 0.010 |
Why?
| Magnetic Resonance Imaging | 1 | 2004 | 1603 | 0.010 |
Why?
| Brain | 1 | 2004 | 1364 | 0.010 |
Why?
|
|
Agarwal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|